Nexpowder

DEVICE2 trials

Sponsors

Next Biomedical Co., Ltd., Changi General Hospital

Conditions

EndoscopyGastroIntestinal BleedingGastrointestinal HemorrhageHematemesis; With Ulcer

Unknown Phase

Effectiveness and Safety of Nexpowder as an Endoscopic Hemostatic Treatment

CompletedNCT05884931

Next Biomedical Co., Ltd.GastroIntestinal Bleeding

Start: 2022-10-18End: 2023-12-29Updated: 2024-02-23

Efficacy and Safety of Nexpowder™ for Non-variceal, Upper Gastrointestinal Bleeding

Changi General HospitalEndoscopy, Gastrointestinal Hemorrhage, Hematemesis; With Ulcer

Start: 2024-02-29End: 2024-12-31Target: 24Updated: 2024-02-21